microMend Overview

  • Founded
  • 2010

Founded
  • Status
  • Private

  • Employees
  • 14

Employees
  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $18M

  • Investors
  • 17

microMend General Information

Description

Developer of wound closure product designed to offer a new alternative to sutures and staples for skin closure. The company's product has the added feature of tiny micro staples that assist it to achieve similar holding strength to sutures and close wounds, enabling medical practitioners to close surgical incisions, lacerations, and skin tears.

Contact Information

Formerly Known As
Marco Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Primary Office
  • 500 Yale Avenue North
  • Suite 100
  • Seattle, WA 98109
  • United States
+1 (877) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

microMend Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 07-Dec-2021 $18M 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series A1) 02-Mar-2017 00000 00.000 00.00 Completed Generating Revenue
4. Angel (individual) 31-Dec-2015 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 23-Dec-2014 00.000 00.000 00.000 Completed Generating Revenue
2. Grant 01-Dec-2012 $1.75M $15K Completed Generating Revenue
1. Early Stage VC 01-Jan-2010 $15K $15K Completed Startup
To view microMend’s complete valuation and funding history, request access »

microMend Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-3 0,000,000 00.000000 00.00 00.00 00 00.00 00.00
Series B-2 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B-1 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A1 809,990 $0.000100 $0.9 $0.9 1x $0.9 3.37%
Series A 4,587,757 $0.000100 $0.61 $0.61 1x $0.61 19.09%
To view microMend’s complete cap table history, request access »

microMend Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of wound closure product designed to offer a new alternative to sutures and staples for skin closure. The comp
Medical Supplies
Seattle, WA
14 As of 2021
000.00
00.00 0000-00-00
00000000000 000.00

00000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
00000000 0000000
Caledonia, MI
0000 As of 0000
00000
0000000 0000

000000

o laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
00000000 0000000
San Luis Obispo, CA
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

microMend Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aspen Surgical Private Equity-Backed Caledonia, MI 0000 00000 0000000 0000
0000000 Venture Capital-Backed San Luis Obispo, CA 00 000.00 00000000000 000.00
000000 0000000 Private Equity-Backed Raleigh, NC 00 00000 0000000000.
000000000 0000000 Venture Capital-Backed Corvallis, OR 00.000 000000000 00.000
0000000 Venture Capital-Backed Paris, France 00 00000 00000000000 00000
You’re viewing 5 of 18 competitors. Get the full list »

microMend Patents

microMend Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220240935-A1 Wound closure device with wide spaced microstructures Pending 29-Jan-2021 0000000000
US-20210252256-A1 Microstructures to attach appliances to tissues Pending 19-Feb-2020 000000000
EP-4106638-A1 Wound closure device for wide treatment areas Pending 19-Feb-2020 0000000000
US-20210251628-A1 Elastic and flexible wound closure device Pending 19-Feb-2020 0000000000 00
US-20210252264-A1 Microstructure systems and methods for pain treatment Pending 19-Feb-2020 A61M37/0015
To view microMend’s complete patent history, request access »

microMend Executive Team (5)

Name Title Board Seat Contact Info
Ronald Berenson MD Co-Founder, President, Chief Executive Officer and Board Member
Eli Sonkin Chief Financial Officer
You’re viewing 2 of 5 executive team members. Get the full list »

microMend Board Members (9)

Name Representing Role Since
Cameron Pollock Self Board Member 000 0000
Edward Truitt JD Self Chairman 000 0000
Henry Kim Self Board Member 000 0000
Jens Quistgaard Ph.D Self Board Member 000 0000
John Brzezenski Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

microMend Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

microMend Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Caygan Capital Hedge Fund Minority 000 0000 000000 0
Elevate Capital Venture Capital Minority 000 0000 000000 0
Keiretsu Capital Venture Capital Minority 000 0000 000000 0
Kyto Technology And Life Science Corporation Minority 000 0000 000000 0
Michigan Capital Network Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »